BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 19471023)

  • 21. Ptk7 promotes non-canonical Wnt/PCP-mediated morphogenesis and inhibits Wnt/β-catenin-dependent cell fate decisions during vertebrate development.
    Hayes M; Naito M; Daulat A; Angers S; Ciruna B
    Development; 2013 Apr; 140(8):1807-18. PubMed ID: 23533179
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of the SH2 domain binding protein of Bruton's tyrosine kinase as BLNK--functional significance of Btk-SH2 domain in B-cell antigen receptor-coupled calcium signaling.
    Hashimoto S; Iwamatsu A; Ishiai M; Okawa K; Yamadori T; Matsushita M; Baba Y; Kishimoto T; Kurosaki T; Tsukada S
    Blood; 1999 Oct; 94(7):2357-64. PubMed ID: 10498607
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel functional screen in human cells identifies MOCA as a negative regulator of Wnt signaling.
    Caspi E; Rosin-Arbesfeld R
    Mol Biol Cell; 2008 Nov; 19(11):4660-74. PubMed ID: 18716063
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bili inhibits Wnt/beta-catenin signaling by regulating the recruitment of axin to LRP6.
    Kategaya LS; Changkakoty B; Biechele T; Conrad WH; Kaykas A; Dasgupta R; Moon RT
    PLoS One; 2009 Jul; 4(7):e6129. PubMed ID: 19572019
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dual functions of Bruton's tyrosine kinase and Tec kinase during Fcgamma receptor-induced signaling and phagocytosis.
    Jongstra-Bilen J; Puig Cano A; Hasija M; Xiao H; Smith CI; Cybulsky MI
    J Immunol; 2008 Jul; 181(1):288-98. PubMed ID: 18566394
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Wnt proteins prevent apoptosis of both uncommitted osteoblast progenitors and differentiated osteoblasts by beta-catenin-dependent and -independent signaling cascades involving Src/ERK and phosphatidylinositol 3-kinase/AKT.
    Almeida M; Han L; Bellido T; Manolagas SC; Kousteni S
    J Biol Chem; 2005 Dec; 280(50):41342-51. PubMed ID: 16251184
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exposure to Therapeutic BTK Inhibitors Induces Phenocopying of
    Hamada-Kawaguchi N; Nore BF; Zain R; Engström Y; Smith CIE; Yamamoto D
    Front Biosci (Landmark Ed); 2023 Jun; 28(6):124. PubMed ID: 37395037
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bruton's tyrosine kinase is required for activation of IkappaB kinase and nuclear factor kappaB in response to B cell receptor engagement.
    Petro JB; Rahman SM; Ballard DW; Khan WN
    J Exp Med; 2000 May; 191(10):1745-54. PubMed ID: 10811867
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bruton tyrosine kinase (BTK) in X-linked agammaglobulinemia (XLA).
    Vihinen M; Mattsson PT; Smith CI
    Front Biosci; 2000 Dec; 5():D917-28. PubMed ID: 11102316
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Wilms tumor suppressor WTX negatively regulates WNT/beta-catenin signaling.
    Major MB; Camp ND; Berndt JD; Yi X; Goldenberg SJ; Hubbert C; Biechele TL; Gingras AC; Zheng N; Maccoss MJ; Angers S; Moon RT
    Science; 2007 May; 316(5827):1043-6. PubMed ID: 17510365
    [TBL] [Abstract][Full Text] [Related]  

  • 31. B cell receptor signaling down-regulates forkhead box transcription factor class O 1 mRNA expression via phosphatidylinositol 3-kinase and Bruton's tyrosine kinase.
    Hinman RM; Bushanam JN; Nichols WA; Satterthwaite AB
    J Immunol; 2007 Jan; 178(2):740-7. PubMed ID: 17202334
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of Bruton's tyrosine kinase in immunodeficiency.
    Tsukada S; Rawlings DJ; Witte ON
    Curr Opin Immunol; 1994 Aug; 6(4):623-30. PubMed ID: 7946052
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bruton's tyrosine kinase is a Toll/interleukin-1 receptor domain-binding protein that participates in nuclear factor kappaB activation by Toll-like receptor 4.
    Jefferies CA; Doyle S; Brunner C; Dunne A; Brint E; Wietek C; Walch E; Wirth T; O'Neill LA
    J Biol Chem; 2003 Jul; 278(28):26258-64. PubMed ID: 12724322
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activation of Bruton's tyrosine kinase (BTK) by a point mutation in its pleckstrin homology (PH) domain.
    Li T; Tsukada S; Satterthwaite A; Havlik MH; Park H; Takatsu K; Witte ON
    Immunity; 1995 May; 2(5):451-60. PubMed ID: 7538439
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mammalian sterile 20-like kinase 1/2 inhibits the Wnt/β-catenin signalling pathway by directly binding casein kinase 1ε.
    Xu F; Wang YL; Chang JJ; Du SC; Diao L; Jiang N; Wang HJ; Ma D; Zhang J
    Biochem J; 2014 Feb; 458(1):159-69. PubMed ID: 24180524
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Involvement of Ras in Bruton's tyrosine kinase-mediated JNK activation.
    Deng J; Kawakami Y; Hartman SE; Satoh T; Kawakami T
    J Biol Chem; 1998 Jul; 273(27):16787-91. PubMed ID: 9642236
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of Bruton's tyrosine kinase in B cells and malignancies.
    Pal Singh S; Dammeijer F; Hendriks RW
    Mol Cancer; 2018 Feb; 17(1):57. PubMed ID: 29455639
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Simplet/Fam53b is required for Wnt signal transduction by regulating β-catenin nuclear localization.
    Kizil C; Küchler B; Yan JJ; Özhan G; Moro E; Argenton F; Brand M; Weidinger G; Antos CL
    Development; 2014 Sep; 141(18):3529-39. PubMed ID: 25183871
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SH3 domain of Bruton's tyrosine kinase can bind to proline-rich peptides of TH domain of the kinase and p120cbl.
    Patel HV; Tzeng SR; Liao CY; Chen SH; Cheng JW
    Proteins; 1997 Dec; 29(4):545-52. PubMed ID: 9408950
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular association between beta-catenin degradation complex and Rac guanine exchange factor DOCK4 is essential for Wnt/beta-catenin signaling.
    Upadhyay G; Goessling W; North TE; Xavier R; Zon LI; Yajnik V
    Oncogene; 2008 Oct; 27(44):5845-55. PubMed ID: 18641688
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.